Search Results
11 Results for 'Metabolic disorders'
PAGE 1 OF 1
Technology
SELECTION SYSTEMS, PEPTIDES DETERMINED THEREWITH, AND METHODS OF USING SAME
UW-Madison inventors have developed a new PACE-based platform for rapid discovery of bioactive cyclic peptide protein aggregation inhibitors. By linking cyclic peptide activity to phage reproduction, ...
Learn More
Learn More
Tina Wang, Linwei Yang | P230455US02
Technology
Activating Appendages To Induce Polypharmacology In Peptide Hormone Analogues, Including Dual GLP-1R / GIP Agonism
UW-Madison researchers have developed a synthetic peptide through a single amino acid substitution and chemical conjugation of an aromatic molecule at the site of mutation that turns a peptide that bi...
Learn More
Learn More
Samuel Gellman, Kyle Brown, Rylie Morris | P230413US02
Technology
Methods For Preventing And Attenuating Hyperphosphatemia
It is disclosed here a method for reducing phosphate absorption in a human or non-human animal subject wherein the subject consumes a diet containing phytic acid or phytate and either has or is at ris...
Learn More
Learn More
Mark Cook, Keith Crawford, Erica Hellestad, Martin Petkovich, Christian Helvig | P06481US
Technology
Compositions And Methods For Treating Hyperphosphatemia In Humans
A method for reducing phosphate absorption in a human or non-human animal subject at risk of developing or having developed hyperphosphatemia is disclosed. The method includes the step of administerin...
Learn More
Learn More
Mark Cook, Keith Crawford, Erica Hellestad, Christian Helvig, Martin Petkovich | P07020US
Technology
Engineered Probiotics as Systemic Therapeutic Delivery Platform
Polypeptides, such as enzymes, antibodies, hormones and cytokines, are useful therapeutic agents. However, routes for systemically introducing such polypeptides to a subject are limited. Oral administ...
Learn More
Learn More
Jan Peter Van Pijkeren, Alan Attie, Mark Keller, Jeehwan Oh | P160109US02
Technology
Novel Small Molecule SIRT6 Activators/Inhibitors
The epigenetic modifier SIRT6 is of the sirtuin class of proteins. In transgenic mice, increased SIRT6 expression lowers LDL and triglyceride levels, improves glucose tolerance and increases mitochond...
Learn More
Learn More
John Denu, Weiping Tang | P160306US01
Technology
Synthesizing Natural Products to Treat High Blood Cholesterol
Indole is one of the most abundant heterocycles in pharmaceuticals and bioactive natural products, such as indometacin, a non-steroid anti-inflammatory drug, and vincristine, a natural product used to...
Learn More
Learn More
Weiping Tang, Dongxu Shu, Gabrielle Winston-McPherson, Xiaoxun Li | P150023US03
Technology
Compounds to Treat Hyperlipidemia and Fatty Liver Disease
Hyperlipidemia is a condition strongly associated with obesity and is an independent risk factor for the development of coronary heart disease. To help combat hyperlipidemia, the pharmaceutical indust...
Learn More
Learn More
Mark Keller, Alan Attie, Sheldon Engelhorn, Nikolai Sepetov, Sergei Romanov, David Bernlohr | P110006US01
Technology
New Compounds for Treating High Blood Cholesterol and More
Indole is one of the most abundant heterocycles in pharmaceuticals and bioactive natural products, such as indometacin, a non-steroid anti-inflammatory drug, and vincristine, a natural product used to...
Learn More
Learn More
Weiping Tang, Xiaoxun Li | P150140US02
Technology
Non-Natural Peptides for Treating Diabetes
Diabetes mellitus continues to be a chronic public health issue despite the availability of injectable insulin since the 1920s. Finding alternative treatments is the subject of intense research. In re...
Learn More
Learn More
Samuel Gellman, Lisa Johnson, Alan Attie, Alan Saghatelian, Mark Keller | P130310US02
Technology
Glycomacropeptide (GMP)-Based Food for the Treatment of PKU and Other Metabolic Disorders
Phenylketonuria (PKU) is a genetic disorder in which an individual lacks the enzyme phenylalanine hydroxylase (PAH) that converts the amino acid phenylalanine into tyrosine. If left untreated, the b...
Learn More
Learn More
Denise Ney, Mark Etzel | P09323US02